Antiphospholipid Antibody Syndrome Active Not Recruiting Phase 2 Trials for Eculizumab (DB01257)

IndicationStatusPhase
DBCOND0029330 (Antiphospholipid Antibody Syndrome)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01029587Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody SyndromePrevention